| Financial Year |
March 31 2023 |
| Monetary Funds |
695,385,197.49 |
| Held-for-trading Financial Assets |
136,087,865.74 |
| Notes Receivable |
475,000.00 |
| Accounts Receivable |
276,577,382.86 |
| Advances to Suppliers |
10,883,905.33 |
| Other Receivables |
11,608,871.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,267,877.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,256,947.84 |
| Total Current Assets |
1,517,679,040.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,211,853.16 |
| Fixed Assetes |
261,939,308.58 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
806,178.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,922,834.15 |
| Deferred Income Tax Assets |
10,716,078.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
306,278,524.83 |
| Total Assets |
1,823,957,565.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,738.44 |
| Accounts Payable |
189,559,039.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,352,426.40 |
| Taxes Payable |
23,594,882.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,656,972.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,975,856.08 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
239,252,337.53 |
| Long-term Loans |
1,149,753.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
473,532.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,570,177.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,831,364.21 |
| Total Liabilities |
269,083,701.74 |
| Paid-In Capital(Or Share Stock) |
172,743,467.00 |
| Capital Surplus |
696,306,300.28 |
| Surplus Reserve |
13,915,514.59 |
| LESS:Treasury Stock |
46,653,276.24 |
| Undistributed Profits |
752,172,611.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,554,873,863.29 |
| Owner's Equity（Stockholder's Equity） |
1,554,873,863.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,823,957,565.03 |
